Grünenthal GmbH

A research-based pharmaceutical manufacturer and an independent family-owned group. For Grünenthal these two concepts are a single entity. Top priority for an entrepreneurial family, management and staff is to maintain and reinforce the economic independence of the group. As regards the future, Grünenthal has its own approach”. Commitment to its own research, internationalisation by carefully selecting new markets for its own subsidiaries and the ability to co-operate with other companies and institutions in research, development and marketing for mutual benefit: these are significant pillars of the Grünenthal approach” to ensure a successful future. This strategy is embodied by Grünenthal’s employees, who have a great sense of commitment and a high degree of responsibility.

Activity:

- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Cardiovascular
- Central nervous system
- Dermatology
- Gastrointestinal
- Infectious Diseases
- Pain
- Respiratory Medicine
- Women's Health

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active: Europe , South America , Asia , Near/Middle East

c. Countries active:

Corporate data:

Number of Employees: 5035

Turnover:

Amount:	Year:	Currency:
716000000	2000	Euro

Year founded: 1946